Gimv is a European investment company listed on Euronext Brussels with over 40 years of private equity experience. It invests directly in companies, mainly using equity on its balance sheet, across the Benelux, France, and DACH regions.
Average disclosed round size is $58.4M (across 23 rounds with reported amounts).
Portfolio
40
Fund Size
—
Top Stage
Series B
Last 12 Mo
4
Team
Tom Van de Voorde*
Managing Partner - Head Smart Industries
Boris Wirtz
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
53 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix | Series B | — | Aug 2026 |
 Exciva | Series B | — | Jan 2026 |
 Kinaset Therapeutics | Series B | $103M | Jan 2026 |
| KKinaset | Series B | $103M | Jan 2026 |
| Exciva | Series B | $59M | Jan 2025 |
 Spineart | Unknown | — | Jan 2025 |
 Fire1 | Unknown | $120M | Jan 2025 |
 Kivu Bioscience | Series A | $92M | Oct 2024 |
 ImmunOS | Unknown | $11M | Sep 2024 |
 ImmunOs | Series C | $11M | Sep 2024 |
 Onera Health | Series C | $32M | Jan 2024 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
| Fire1 | Unknown | $25M | Mar 2023 |
 Paleo | Series A | $12.7M | Feb 2023 |
| JJenaValve Technology | Series C | $100M | Aug 2022 |
| JJenaValve | Unknown | $100M | Aug 2022 |
 ImCheck | Series C | — | Jun 2022 |
| ImmunOS | Series B | $74M | Jun 2022 |
| ImmunOs | Series B | $74M | Jun 2022 |
 PRECIRIX NV | Series B | — | Mar 2022 |
| Complement Therapeutics | Seed | — | Feb 2022 |
 JenaValve Technology | Series C | $100M | Jan 2022 |
 Topas Therapeutics | Series B | — | Jul 2021 |
 SynOx Therapeutics Ltd | Series A | — | Nov 2020 |
Page 1 of 3
Top Co-Investors
EQT Life Sciences12 shared
Andera Partners10 shared
Forbion6 shared
HealthCap6 shared
BioMed Ventures6 shared
Pfizer Ventures6 shared
Atlas Venture5 shared
Cormorant Asset Management5 shared
Alta Partners5 shared
Omega Funds5 shared
Novo Capital4 shared
Mission BioCapital4 shared
Vi Partners4 shared
Legend Capital4 shared
Bain Capital Life Sciences4 shared
Gilde Healthcare4 shared
imec.xpand3 shared
Invest-NL3 shared
Last updated: 8 September 2026